Skip to main content

Table 6 The parameters of RILD patients before and after SBRT

From: Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm)

 

ALP

Bilirubin

ALT

AST

ALB

Ascites

Pre-

Post-

Pre-

Post-

Pre-

Post-

Pre-

Post-

Pre-

Post-

Pre-

Post-

Classic RILD

131

341

9.8

9.5

28

39

32

32

43

36

–

–

67

80

12.8

9.9

43

34

43

29

46

35

–

++

59

327

14.5

8.4

13

18

16

29

44

41

–

+

113

362

7.8

8.2

16

31

46

38

42

44

–

–

Non-Classic RILD

67

136

22.7

51.6

30

608

28

363

36

40

–

–

79

81

18.5

35.6

28

17

37

42

39

34

–

–

79

116

12

16

22

214

27

223

34

33

–

–

73

147

26.1

51.4

34

749

42

678

36

32

–

+

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us